Man Group PLC Haemonetics Corp Transaction History

Man Group PLC

$35.6 Billion
Q4 2024

A detailed history of Man Group PLC transactions in Haemonetics Corp stock. As of the latest transaction made, Man Group PLC holds 3,098 shares of HAE stock, worth $195,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,098

Previous 24,609 87.41%

Holding current value

$195,235

Previous $1.98 Million 87.81%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$71.16 - $93.38 $1.53 Million - $2.01 Million	-21,511 Reduced 87.41%	3,098 $241,000
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $338,269 - $427,587	4,669 Added 23.42%	24,609 $1.98 Million
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $4.28 Million - $5.13 Million	-52,723 Reduced 72.56%	19,940 $1.65 Million
Q1 2024 May 15, 2024	BUY	$71.24 - $85.35 $2.5 Million - $2.99 Million	35,034 Added 93.1%	72,663 $6.2 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $2.47 Million - $2.84 Million	-30,652 Reduced 44.89%	37,629 $3.22 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $1.97 Million - $2.23 Million	-23,876 Reduced 25.91%	68,281 $6.12 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $2.21 Million - $2.45 Million	27,378 Added 42.26%	92,157 $7.85 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $478,476 - $595,876	-6,577 Reduced 9.22%	64,779 $5.36 Million
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $162,691 - $189,766	-2,203 Reduced 2.99%	71,356 $5.61 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $2.08 Million - $2.59 Million	-32,869 Reduced 30.88%	73,559 $5.45 Million
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $128,446 - $172,270	-2,607 Reduced 2.39%	106,428 $6.94 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $15,538 - $22,443	-355 Reduced 0.32%	109,035 $6.89 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $59,113 - $88,985	1,193 Added 1.1%	109,390 $5.8 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $131,500 - $161,156	2,283 Added 2.16%	108,197 $7.64 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $4.2 Million - $9.61 Million	81,042 Added 325.84%	105,914 $7.06 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $271,086 - $340,610	2,442 Added 10.89%	24,872 $2.76 Million
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $4.64 Million - $6.27 Million	-52,295 Reduced 69.98%	22,430 $2.66 Million
Q3 2020 Nov 16, 2020	SELL	$75.65 - $93.58 $4.29 Million - $5.3 Million	-56,646 Reduced 43.12%	74,725 $6.52 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $4.18 Million - $5.85 Million	49,160 Added 59.8%	131,371 $11.8 Million
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $35,311 - $57,864	-475 Reduced 0.57%	82,211 $8.19 Million
Q4 2019 Feb 18, 2020	SELL	$114.37 - $129.46 $10.8 Million - $12.2 Million	-94,353 Reduced 53.3%	82,686 $9.5 Million
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $684,917 - $809,787	5,846 Added 3.41%	177,039 $22.3 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $802,686 - $1.18 Million	-9,820 Reduced 5.43%	171,193 $20.6 Million
Q1 2019 May 15, 2019	SELL	$83.25 - $102.12 $3.45 Million - $4.23 Million	-41,443 Reduced 18.63%	181,013 $15.8 Million
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $43.6 Million - $56.1 Million	-480,664 Reduced 68.36%	222,456 $22.3 Million
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $8.17 Million - $10.4 Million	90,823 Added 14.83%	703,120 $80.6 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $34.4 Million - $46.1 Million	481,439 Added 367.91%	612,297 $54.9 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $7.95 Million - $9.74 Million	130,858 New	130,858 $9.57 Million

Others Institutions Holding HAE

# of Institutions

349

Shares Held

55.7M

Call Options Held

600K

Put Options Held

474K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.23B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account